Page last updated: 2024-08-25

rosiglitazone and Orphan Diseases

rosiglitazone has been researched along with Orphan Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hernandez, AV; Ioannidis, JP; Kattan, MW; Walker, E	1

Reviews

1 review(s) available for rosiglitazone and Orphan Diseases

Article	Year
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. American heart journal, 2008, Volume: 156, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Incidence; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Rare Diseases; Reproducibility of Results; Risk Assessment; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones	2008

Article

Year

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.

American heart journal, 2008, Volume: 156, Issue:1

Topics: Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Incidence; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Rare Diseases; Reproducibility of Results; Risk Assessment; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones

2008